Chris Nolet is of Revance Therapeutics, Inc.. Currently has a direct ownership of 0 shares of RVNC, which is worth approximately $0. The most recent transaction as insider was on Feb 06, 2025, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Chris Nolet Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
SELL
Sale (or disposition) back to the issuer
-
15,000 Reduced 100.0%
0 Common Stock
Feb 04 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$104,411 $3.65 p/Share
28,606 Reduced 65.6%
15,000 Common Stock
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 25.59%
43,606 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
3,534 Added 11.0%
28,606 Common Stock
May 04 2022
BUY
Grant, award, or other acquisition
-
6,059 Added 19.46%
25,072 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
4,013 Added 17.43%
19,013 Common Stock

Also insider at

PTE
POLARITYTE, INC. Healthcare
VIE
Viela Bio, Inc.
JSPR
Jasper Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
CN

Chris Nolet

Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC